Funding Opportunities

Title Announcement Number Activity Code Clinical Trials Status Expiration Date Sort descending Program Official
Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for PA-20-222: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) NOT-NS-20-107 Clinical Trial Not Allowed 05/16/2024
Notice of Special Interest (NOSI): HEAL Initiative: Clinical Translation of Diagnostic and Therapeutic Devices via Blueprint MedTech NOT-NS-23-002 06/21/2024
Consortium for Palliative Care Research Across the Lifespan RFA-AG-25-002 (U54 Clinical Trial Optional) U54 Clinical Trial Optional 07/03/2024 Brennan Streck, Ph.D., R.N., M.P.H.
Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: Advancing Health Care towards Health Equity PAR-22-092 (R01 - Clinical Trials Optional) R01 09/08/2024 Ellen Richmond, M.S., G.N.P.-B.C.
Notice of Special Interest (NOSI): Improving Outcomes in Cancer Treatment-Related Cardiotoxicity NOT-CA-22-001 11/06/2024
HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment RFA-NS-22-034 (R01 Clinical Trial Not Allowed) R01 Clinical Trial Not Allowed 12/07/2024 Rachel Altshuler, Ph.D.
Notice of Intent to Publish a Funding Opportunity Announcement for Consortium for Palliative Care Research Across the Lifespan NOT-AG-23-050 (U54 Clinical Trial Required) U54 Clinical Trial Required 12/31/2024 Brennan Streck, Ph.D., R.N., M.P.H.
Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities PAR-22-064 (R01 Clinical Trial Optional) R01 Clinical Trial Optional 01/08/2025
HEAL Initiative: Understanding Individual Differences in Human Pain Conditions RFA-NS-24-021 (R01 - Clinical Trial Optional) R01 Clinical Trial Optional 02/07/2025 Rachel Altshuler, Ph.D.
HEAL Initiative: Interdisciplinary Team Science to Uncover the Mechanisms of Pain Relief by Medical Devices RFA-NS-23-003 (RM1 Clinical Trial Optional) RM1 Clinical Trial Optional 06/10/2025